Drug Shortage Report for FRAXIPARINE FORTE

Last updated on 2020-12-05 History
Report ID 129620
Drug Identification Number 02450674
Brand name FRAXIPARINE FORTE
Common or Proper name Fraxiparine® Forte (nadroparin calcium injection (0.6 mL)
Company Name ASPEN PHARMACARE CANADA INC.
Market Status DORMANT
Active Ingredient(s) NADROPARIN CALCIUM
Strength(s) 19000UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size 10 PF Syringe
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-12-04
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-12-05
Company comments N/A
Health Canada comments
Tier 3 Status No
Contact Address UNIT 8, 1155 NORTH SERVICE ROAD WEST
OAKVILLE, ONTARIO
CANADA L6M 3E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-12-05 English Compare
v2 2020-12-04 French Compare
v1 2020-12-04 English Compare

Showing 1 to 3 of 3